| 产品名称： | Bacteroides fragilis (Veillon and Zuber) Castellani and Chalmers |
|---|---|
| 商品货号： | TS213114 |
| Strain Designations： | VPI 2553 EN-2; NCTC 9343 |
| Application： | Media testing
Quality control strain
Susceptibility testing
Quality control strain for BBL and MicroScan® products
Pharmaceutical and Personal Care |
| Isolation： | Appendix abscess |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®： | yes |
| Genome Sequenced Strain： | Bacteroides fragilis NCTC 9343, complete genome |
| Type Strain： | yes |
| Comments： | Genome sequenced strain |
| Medium： | ATCC® Medium 1490: Modified chopped meat medium ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood |
| Growth Conditions： | Temperature: 37°C
Atmosphere: Anaerobic |
| Name of Depositor： | WE Moore |
| Chain of Custody： | ATCC |
| References： | Cato EP, Johnson JL. Reinstatement of species rank for Bacteroides fragilis, B. ovatus, B. distasonis, B. thetaiotaomicron, and B. vulgatus: Designation of neotype strains for Bacteroides fragilis (Veillon and Zuber) Castellani and Chalmers and Bacteroides thetaiotaomicron (Distaso) Castellani and Chalmers. Int. J. Syst. Bacteriol. 26: 230-237, 1976. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria. Wayne, PA. Clinical and Laboratory Standards Institute; CLSI M11-A7. Quality Control for Commercially Prepared Microbiological Culture Media; Approved Standard - 3rd Edition. Wayne, PA. Clinical and Laboratory Standards Institute; CLSI M22-A3. Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980. Takahata M, Nishino T. Antibacterial activities of tosufloxacin against anaerobic bacteria and the electron micrograph of its bactericidal effects. Chemotherapy 43: 153-158, 1997. PubMed: 9142454 BD Crystal ANR QC Set. BD Becton Dickinson; Crystal MicroScan Rapid Anaerobe ID QC Set. Dade/Siemens. Sensititre™ Anaerobe MIC Susceptibility. Thermo Scientific™ Sensititre™ Systems, Trek Diagnostic Systems. Quality Control of Microbiological Transport Systems; Approved Standard. Wayne, PA. Clinical and Laboratory Standards Institute; CLSI M40-A. Medical microbiology--Culture media -- Part 4: Transport systems for specimens containing bacteria. Berlin, Germany:Deutsches Institut fur Normung;DIN DIN 58942-4: 2003, 2003 |
| Cross References： | Nucleotide (GenBank) : X83935 B.fragilis 16S rRNA (TS213114T). Nucleotide (GenBank) : AX110196 Sequence 929 from Patent WO0123604. Nucleotide (GenBank) : AF280705 Bacteroides fragilis isolate TS213114 RecA (recA) gene, partial cds. Nucleotide (GenBank) : U05887 Bacteroides fragilis TS213114 beta-lactamase (cepA-85) gene, complete cds. Nucleotide (GenBank) : AF280642 Bacteroides fragilis isolate TS213114 glutamine synthetase (glnA) gene, partial cds. Nucleotide (GenBank) : CR626927 Bacteroides fragilis NCTC 9343, complete genome |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Bacteroides fragilis (Veillon and Zuber) Castellani and Chalmers |
|---|---|
| 商品货号： | TS213114 |
| Strain Designations： | VPI 2553 EN-2; NCTC 9343 |
| Application： | Media testing
Quality control strain
Susceptibility testing
Quality control strain for BBL and MicroScan® products
Pharmaceutical and Personal Care |
| Isolation： | Appendix abscess |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Preceptrol®： | yes |
| Genome Sequenced Strain： | Bacteroides fragilis NCTC 9343, complete genome |
| Type Strain： | yes |
| Comments： | Genome sequenced strain |
| Medium： | ATCC® Medium 1490: Modified chopped meat medium ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood |
| Growth Conditions： | Temperature: 37°C
Atmosphere: Anaerobic |
| Name of Depositor： | WE Moore |
| Chain of Custody： | ATCC |
| References： | Cato EP, Johnson JL. Reinstatement of species rank for Bacteroides fragilis, B. ovatus, B. distasonis, B. thetaiotaomicron, and B. vulgatus: Designation of neotype strains for Bacteroides fragilis (Veillon and Zuber) Castellani and Chalmers and Bacteroides thetaiotaomicron (Distaso) Castellani and Chalmers. Int. J. Syst. Bacteriol. 26: 230-237, 1976. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria. Wayne, PA. Clinical and Laboratory Standards Institute; CLSI M11-A7. Quality Control for Commercially Prepared Microbiological Culture Media; Approved Standard - 3rd Edition. Wayne, PA. Clinical and Laboratory Standards Institute; CLSI M22-A3. Skerman VB, et al. Approved lists of bacterial names. Int J Syst Bacteriol 30: 225-420, 1980. Takahata M, Nishino T. Antibacterial activities of tosufloxacin against anaerobic bacteria and the electron micrograph of its bactericidal effects. Chemotherapy 43: 153-158, 1997. PubMed: 9142454 BD Crystal ANR QC Set. BD Becton Dickinson; Crystal MicroScan Rapid Anaerobe ID QC Set. Dade/Siemens. Sensititre™ Anaerobe MIC Susceptibility. Thermo Scientific™ Sensititre™ Systems, Trek Diagnostic Systems. Quality Control of Microbiological Transport Systems; Approved Standard. Wayne, PA. Clinical and Laboratory Standards Institute; CLSI M40-A. Medical microbiology--Culture media -- Part 4: Transport systems for specimens containing bacteria. Berlin, Germany:Deutsches Institut fur Normung;DIN DIN 58942-4: 2003, 2003 |
| Cross References： | Nucleotide (GenBank) : X83935 B.fragilis 16S rRNA (TS213114T). Nucleotide (GenBank) : AX110196 Sequence 929 from Patent WO0123604. Nucleotide (GenBank) : AF280705 Bacteroides fragilis isolate TS213114 RecA (recA) gene, partial cds. Nucleotide (GenBank) : U05887 Bacteroides fragilis TS213114 beta-lactamase (cepA-85) gene, complete cds. Nucleotide (GenBank) : AF280642 Bacteroides fragilis isolate TS213114 glutamine synthetase (glnA) gene, partial cds. Nucleotide (GenBank) : CR626927 Bacteroides fragilis NCTC 9343, complete genome |
